Reviewer #2 (Public Review): Predicting the effect of CRISPR-Cas9-based epigenome editing
Year: 2023
Type: peer-review
Source: eLife
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,500
OpenAlex ID: W4389987848
